Pyrimido[5,4-d]pyrimidin-4-amine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: Pyrimido[5,4-d]pyrimidin-4-amine
• 英文别名: pyrimido[5,4-d]pyrimidin-4-amine
• 化学式: C₆H₅N₅
• 分子量: 147.14
• InChiKey: BYSFISKKPBELHQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.4
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  77.6
• 氢给体数：
  1
• 氢受体数：
  5

文献信息

• MNK INHIBITORS AND METHODS RELATED THERETO
  申请人：eFFECTOR Therapeutics, Inc.

  公开号：US20160317536A1

  公开（公告）日：2016-11-03

  The present invention relates to compounds according to Formula (I): or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, wherein R 1 , R 2 , R 3 , R 4a , R 4b , R 5 , R 6 , R 7 , R 8 , W 1 , W 2 , Y and n are as defined herein. Also described are pharmaceutically acceptable compositions of Formula I compounds as well as methods for utilizing the compounds of Formula I and the pharmaceutically acceptable compositions of Formula I compounds as inhibitors of Mnk as well as therapeutics for the treatment of diseases such as cancer.

  本发明涉及按照式（I）表示的化合物：或其立体异构体、互变异构体或药学上可接受的盐，其中R1、R2、R3、R4a、R4b、R5、R6、R7、R8、W1、W2、Y和n如本文所定义。还描述了按照式（I）化合物的药学上可接受的组合物，以及利用式（I）化合物和药学上可接受的式（I）化合物组合物作为Mnk抑制剂以及治疗癌症等疾病的治疗剂的方法。
• US9382248B2
  申请人：——

  公开号：US9382248B2

  公开（公告）日：2016-07-05
• US9669031B2
  申请人：——

  公开号：US9669031B2

  公开（公告）日：2017-06-06
• US9814718B2
  申请人：——

  公开号：US9814718B2

  公开（公告）日：2017-11-14
• [EN] MNK INHIBITORS AND METHODS RELATED THERETO<br/>[FR] INHIBITEURS DE MNK ET PROCÉDÉS ASSOCIÉS
  申请人：EFFECTOR THERAPEUTICS INC

  公开号：WO2015200481A1

  公开（公告）日：2015-12-30

  The present invention relates to compounds according to Formula (I): or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4a, R4b, R5, R6, R7, R8, W1, W2, Y and n are as defined herein. Also described are pharmaceutically acceptable compositions of Formula (I) compounds as well as methods for utilizing the compounds of Formula (I) and the pharmaceutically acceptable compositions of Formula (I) compounds as inhibitors of Mnk as well as therapeutics for the treatment of diseases such as cancer.